Published in
American Society of Hematology, Blood, 15(129), p. 2120-2123
DOI: 10.1182/blood-2016-12-756528
Links
Tools
A phase 2 trial of pomalidomide and dexamethasone rescue treatment in patients with AL amyloidosis
Journal article published in 2017 by
Giovanni Palladini 
,
Paolo Milani,
Andrea Foli,
Marco Basset ,
Francesca Russo,
Stefano Perlini,
Giampaolo Merlini
,
Paolo Milani,
Andrea Foli,
Marco Basset ,
Francesca Russo,
Stefano Perlini,
Giampaolo Merlini
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points PDex can be a rescue regimen for patients with AL amyloidosis previously exposed to alkylators, proteasome inhibitors, and lenalidomide. Responses to PDex are frequent, rapid, and improve survival.